Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Insufficient chart data. Estimates will improve as the show charts.
- Per-Episode Audience
Est. listeners per new episode within ~30 days
N/A🎙 Weekly cadence·35 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
N/A - Active Followers
Loyal subscribers who consistently listen
N/A
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHosts
Not detected.
Recent guests
Recent episodes
Sven Francque, MD, PhD - The Gastroenterologist’s Guide to Finding and Managing MASH With Fibrosis: Practical Strategies for Everyday Practice
May 18, 2026
35m 42s
Javier Ampuero, MD, PhD - Making MASH a Priority in Our Gastroenterology Practices: Why We Should and How We Can
Apr 29, 2026
20m 02s
Jörn M. Schattenberg, MD - Cases in Contemporary MASH Management: Expert Insights on the Practical Integration of Disease-Specific Pharmacotherapy
Dec 31, 2025
34m 23s
Naim Alkhouri, MD, FAASLD, DABOM - Don’t Wait, and Look Beyond Weight: The Growing Case for Urgent and Comprehensive Management of MASH
Dec 23, 2025
20m 31s
Kris V. Kowdley, MD - Advancing the Management of Cholestatic Liver Disease: Optimizing Treatment Pathways and Novel Therapies
Dec 17, 2025
1h 17m 30s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 5/18/26 | Sven Francque, MD, PhD - The Gastroenterologist’s Guide to Finding and Managing MASH With Fibrosis: Practical Strategies for Everyday Practice✨ | gastroenterologyMASH+3 | Sven Francque, MD, PhD | — | — | gastroenterologistMASH+3 | — | 35m 42s | |
| 4/29/26 | Javier Ampuero, MD, PhD - Making MASH a Priority in Our Gastroenterology Practices: Why We Should and How We Can✨ | gastroenterologyMASH+3 | Javier Ampuero, MD, PhD | — | — | MASHgastroenterology+3 | — | 20m 02s | |
| 12/31/25 | Jörn M. Schattenberg, MD - Cases in Contemporary MASH Management: Expert Insights on the Practical Integration of Disease-Specific Pharmacotherapy✨ | MASH ManagementPharmacotherapy+3 | Jörn M. Schattenberg, MD | — | — | MASH ManagementPharmacotherapy+3 | — | 34m 23s | |
| 12/23/25 | Naim Alkhouri, MD, FAASLD, DABOM - Don’t Wait, and Look Beyond Weight: The Growing Case for Urgent and Comprehensive Management of MASH✨ | MASH managementweight management+3 | Naim Alkhouri, MD, FAASLD, DABOM | — | — | MASHmanagement+3 | — | 20m 31s | |
| 12/17/25 | Kris V. Kowdley, MD - Advancing the Management of Cholestatic Liver Disease: Optimizing Treatment Pathways and Novel Therapies✨ | Cholestatic Liver DiseaseManagement+3 | Kris V. Kowdley, MD | — | — | cholestatic liver diseasetreatment pathways+3 | — | 1h 17m 30s | |
| 5/27/25 | Marla C. Dubinsky, MD / David T. Rubin, MD - TNF Inhibitors in Inflammatory Bowel Disease: How Can We Realize Opportunities to Optimize Clinical and Patient Outcomes?✨ | Inflammatory Bowel DiseaseTNF Inhibitors+3 | Marla C. Dubinsky, MDDavid T. Rubin, MD | PeerVoice | — | TNF InhibitorsInflammatory Bowel Disease+3 | — | 57m 01s | |
| 1/13/25 | Albrecht Stenzinger, MD - Optimising the Molecular Profiling Journey for Patients With CCA: Applying Best Practices and Avoiding Pitfalls✨ | molecular profilingcholangiocarcinoma+3 | Albrecht Stenzinger, MD | — | — | molecular profilingcholangiocarcinoma+3 | — | 25m 39s | |
| 1/3/25 | Olivier Bonnot, MD, PhD - Acute Psychosis: When to Suspect Acute Hepatic Porphyria✨ | acute psychosisacute hepatic porphyria+3 | Olivier Bonnot, MD, PhD | — | — | acute psychosisacute hepatic porphyria+3 | — | 17m 58s | |
| 1/2/25 | Darren M. Brenner / Benoît Coffin - If I'd Known Then What I Know Now: Recognising My First AHP Patient✨ | AHPpatient recognition+3 | Darren M. BrennerBenoît Coffin | — | — | AHPpatient care+3 | — | 18m 40s | |
| 12/27/24 | Darren M. Brenner, MD - If I'd Known Then What I Know Now: Recognising My First AHP Patient (Rebroadcast)✨ | AHPpatient recognition+3 | Darren M. Brenner, MD | — | — | AHPpatient care+3 | — | 18m 37s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 11/8/24 | Ffion Davies, MBChB, FRCPCH, FRCEM - Managing Major Bleeding in Patients Receiving DOACs: Data, Developments, and Decision-Making in the ED | Ffion Davies, MBChB, FRCPCH, FRCEM - Managing Major Bleeding in Patients Receiving DOACs: Data, Developments, and Decision-Making in the ED | — | ||||||
| 9/30/24 | Deborah Siegal, MD, MSc, FRCPC / Richard Body, MBChB, FRCEM, PhD - Turn the Bleed Around: Expert Perspectives on the Evolving Evidence for Management of Factor Xa Inhibitor-Associated Life-Threatening Bleeding | Deborah Siegal, MD, MSc, FRCPC / Richard Body, MBChB, FRCEM, PhD - Turn the Bleed Around: Expert Perspectives on the Evolving Evidence for Management of Factor Xa Inhibitor-Associated Life-Threatening Bleeding | — | ||||||
| 2/27/24 | Marwan Fakih, MD - The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Second Line | Marwan Fakih, MD - The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Second Line | — | ||||||
| 2/1/24 | Marwan Fakih, MD - Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC | Marwan Fakih, MD - Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC | — | ||||||
| 12/28/23 | Philip James Tozer, MBBS, MD(Res), FRCS - Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring the Who, When, and How for Stem Cell Therapy | Philip James Tozer, MBBS, MD(Res), FRCS - Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring the Who, When, and How for Stem Cell Therapy | — | ||||||
| 12/19/23 | Angela Lamarca, MD, PhD, MSc - Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplinary Care, Molecular Testing, and Targeted Treatment | Angela Lamarca, MD, PhD, MSc - Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplinary Care, Molecular Testing, and Targeted Treatment | — | ||||||
| 12/8/23 | Andreas Kremer, MD, PhD, MHBA - Initiating the Conversation on Itch: Modelling Best Practices in Patient-Centred Care for Cholestatic Pruritus in PBC | Andreas Kremer, MD, PhD, MHBA - Initiating the Conversation on Itch: Modelling Best Practices in Patient-Centred Care for Cholestatic Pruritus in PBC | — | ||||||
| 11/10/23 | Andreas Kremer, MD, PhD, MHBA - Incorporating the Investigation of Itch Into the Patient Care Process for PBC: Practical Steps, Tips, and Tools | Andreas Kremer, MD, PhD, MHBA - Incorporating the Investigation of Itch Into the Patient Care Process for PBC: Practical Steps, Tips, and Tools | — | ||||||
| 7/31/23 | Arndt Vogel, MD - Modern Management of Cholangiocarcinoma: Sharing Evidence, Experience, and Expertise | Arndt Vogel, MD - Modern Management of Cholangiocarcinoma: Sharing Evidence, Experience, and Expertise | — | ||||||
| 6/13/23 | Geoffrey Ku, MD - Here’s The Challenge! Overcoming Tumour Heterogeneity in Gastric/GEJ Cancers | Geoffrey Ku, MD - Here’s The Challenge! Overcoming Tumour Heterogeneity in Gastric/GEJ Cancers | — | ||||||
| 5/18/23 | Nick Pavlakis, MBBS, PLD / Kohei Shitara, MD - The Evolution of Treatment for Advanced Gastric and Oesophageal Cancers: New Insights From Key Congresses | Nick Pavlakis, MBBS, PLD / Kohei Shitara, MD - The Evolution of Treatment for Advanced Gastric and Oesophageal Cancers: New Insights From Key Congresses | — | ||||||
| 3/23/23 | Tanios Bekaii-Saab, MD - Expert Perspectives on Treatment Sequencing in Advanced CRC: Keys to Reaching Later Lines of Therapy | Tanios Bekaii-Saab, MD - Expert Perspectives on Treatment Sequencing in Advanced CRC: Keys to Reaching Later Lines of Therapy | — | ||||||
| 3/23/23 | Gerald Prager, MD - Don't Leave a Drug on the Table: Maximising Use and Benefits of Later-Line Treatments for Advanced Colorectal Cancer | Gerald Prager, MD - Don't Leave a Drug on the Table: Maximising Use and Benefits of Later-Line Treatments for Advanced Colorectal Cancer | — | ||||||
| 2/17/23 | David T. Rubin, MD, AGAF - What They Say and What They Think: Exploring Tools for Assessing Bowel Urgency in Patients with Ulcerative Colitis | David T. Rubin, MD, AGAF - What They Say and What They Think: Exploring Tools for Assessing Bowel Urgency in Patients with Ulcerative Colitis | — | ||||||
| 2/3/23 | Mauro Bernardi, MD - The Functional Quality of Albumin in Fluid Management of Patients with Liver Cirrhosis: Just a Concept or Does it Matter? | Mauro Bernardi, MD - The Functional Quality of Albumin in Fluid Management of Patients with Liver Cirrhosis: Just a Concept or Does it Matter? | — | ||||||
Showing 25 of 37
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.